Stand Up To Cancer announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including head and neck, pediatric, pancreatic, breast, rectal, and gastro-esophageal cancers, as well as research focused on how the microbiome communicates with the immune system.
Cigall Kadoch was named the laureate of the Blavatnik National Awards for Young Scientists in the field of life sciences for her work in cancer biology.
CureSearch for Children’s Cancer will award $2 million in funding to support a phase I clinical trial in 24 children and young adults with recurrent brain tumors.
Cheng-Chia “Fred” Wu, a physician-scientist who treats brain tumors in children, has joined Virginia Tech to bring his expertise in focused ultrasound cancer research to the Fralin Biomedical Research Institute at Virginia Tech Carilion.
Socioeconomic factors can influence the diagnosis and treatment of children in Texas with malignant solid tumors, increasing the risk of the cancer’s spread and lowering the five-year survival rate, according to researchers at UT Southwestern Medical Center.
The UF Health Proton Therapy Institute enhanced its playroom, a respite for its pediatric patients, significantly with innovative technology that promotes therapeutic engagement, with an 86” interactive gaming wall that features educational and sensory software.
Researchers from the University of Southern California found a genetic variant contributing to disparities in childhood leukemia risk. The variant, located on the IKZF1 gene, helps explain why Hispanic/Latino children face a higher risk of acute lymphoblastic leukemia and offers insights about what causes the disease.
Joshua Cohn, associate professor in the Department of Urology at Fox Chase Cancer Center and a member of the Fox Chase – Temple Urologic Institute, was named a consultant at Shriners Children’s Philadelphia.
The largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure found that carvedilol, a blood vessel relaxing medication, is safe for childhood cancer survivors and may improve important markers of heart injury sustained as a result of chemotherapy exposure.
Debra Friedman, E. Bronson Ingram Chair in Pediatric Oncology, was named deputy director of Vanderbilt-Ingram Cancer Center.
